ARTICLE | Clinical News
THX-TS01: Ph IIa started
January 12, 2017 12:46 AM UTC
Therapix began an open-label, U.S. Phase IIa trial to evaluate once-daily oral THX-TS01 in about 18 patients....
BCIQ Company Profiles
Therapix began an open-label, U.S. Phase IIa trial to evaluate once-daily oral THX-TS01 in about 18 patients....
BCIQ Company Profiles